0 works0 citations0 h-indexGoogle ScholarOpenAlexMeng-Chung LungFountain Biopharma (Taiwan)(TW)Research AreasAsthma and respiratory diseases, Mast cells and histamine, Urticaria and Related ConditionsMost-Cited Works→ IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms(2022)51 cited